双途径介入治疗晚期肺癌

 我们自1990年至1993年, 对87例晚期肺癌患者采用支气管动脉及肺动脉双途径介入化疗, 收到满意疗效。 术后平均生存18个月。 与此同期单纯支气管动脉介入200例, 术后平均生存10.5个月, 经过双途径介入化疗大部分病人临床症状缓解, 提高了生活质量, 部分病人重新获得了手术机会, 生存期较单纯支气管动脉介入明显延长。 表明肺动脉与支气管动脉同时介入, 较单纯支气管动脉介入化疗疗效好, 可以互相弥补其不足, 更广泛地杀死癌细胞。 是一种有效的姑息治疗手段。

Two Route Interventional Chemotherapy in the Treatment of Later Lung Cancer

cases of later lung cancer were treated by Two Route arterial Chemotherapy (TRAC) viabronchial artery and pulmonary artery. They were all stage Ⅲ-Ⅳ cases (TNM stages) in thisgroup. Selective bronchial arteriography showed the tumer's nourishing blood vessels. TRIC wasperformed injection the bronchial artery with CBP 300mg, ADM 30mg and VP-16 300mg; followed injection the pulmonary artery with VCR ling and MMC 4mg, 5-Fu 500mg etc for ten days. Goood results were achieved CR 90.87% of cases; PR 55.17%; MR 35.63%; NC 5.7%, PD 3.4%. TRAC was an effective palliative treatment way in later lung cancer.